Clinical Trial Update: Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oxaliplatin for persistent or recurrent endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED